FDA Hit With Suit Over Reporting Leeway For Clinical Trials
By Adam Lidgett (December 10, 2018, 8:01 PM EST) -- A New York University faculty member and a former U.S. Food and Drug Administration official have hit the agency with a suit challenging a rule they said relaxed the reporting requirements for researchers doing certain clinical trials.
Journalism professor Charles Seife and Peter Lurie, ex-associate commissioner for public health strategy and analysis at the FDA, filed the complaint in New York federal court Friday against the agency, the U.S. Department of Health and Human Services, and the National Institutes of Health. The complaint said that the final rule creates certain requirements for registering clinical trials and reporting their results, but that...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!